BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 28881249)

  • 1. Cost-effectiveness analysis of PET-CT-guided management for locally advanced head and neck cancer.
    Smith AF; Hall PS; Hulme CT; Dunn JA; McConkey CC; Rahman JK; McCabe C; Mehanna H
    Eur J Cancer; 2017 Nov; 85():6-14. PubMed ID: 28881249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.
    Mehanna H; McConkey CC; Rahman JK; Wong WL; Smith AF; Nutting C; Hartley AG; Hall P; Hulme C; Patel DK; Zeidler SV; Robinson M; Sanghera B; Fresco L; Dunn JA
    Health Technol Assess; 2017 Apr; 21(17):1-122. PubMed ID: 28409743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.
    Sher DJ; Tishler RB; Annino D; Punglia RS
    Ann Oncol; 2010 May; 21(5):1072-7. PubMed ID: 19833820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness Analysis of Elective Neck Dissection in Patients With Clinically Node-Negative Oral Cavity Cancer.
    Acevedo JR; Fero KE; Wilson B; Sacco AG; Mell LK; Coffey CS; Murphy JD
    J Clin Oncol; 2016 Nov; 34(32):3886-3891. PubMed ID: 27551113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.
    Pryor DI; Porceddu SV; Scuffham PA; Whitty JA; Thomas PA; Burmeister BH
    Head Neck; 2013 Sep; 35(9):1287-94. PubMed ID: 22987817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cost-utility analysis comparing CT surveillance, PET-CT surveillance, and planned postradiation neck dissection for advanced nodal HPV-positive oropharyngeal cancer.
    Fu TS; Scheffler P; Forner D; Noel CW; Huang SH; Gilbert RW; Goldstein DP; O'Sullivan B; Mehanna HM; Waldron J; de Almeida JR
    Cancer; 2021 Sep; 127(18):3372-3380. PubMed ID: 34062618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of intensive radiological assessments in routine surveillance after treatment for head and neck cancer: An economic evaluation.
    Meregaglia M; Cairns J; Licitra L; Bossi P
    Eur J Cancer; 2018 Apr; 93():89-98. PubMed ID: 29477796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elective neck dissection versus positron emission tomography-computed tomography-guided management of the neck in clinically node-negative early oral cavity cancer: A cost-utility analysis.
    Noel CW; Forner D; Goldstein DP; Metser U; Ferris RL; Waldron J; de Almeida JR
    Cancer; 2021 Jun; 127(12):1993-2002. PubMed ID: 33635537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.
    Mehanna H; Wong WL; McConkey CC; Rahman JK; Robinson M; Hartley AG; Nutting C; Powell N; Al-Booz H; Robinson M; Junor E; Rizwanullah M; von Zeidler SV; Wieshmann H; Hulme C; Smith AF; Hall P; Dunn J;
    N Engl J Med; 2016 Apr; 374(15):1444-54. PubMed ID: 27007578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CT, MRI, and F-18 FDG PET/CT for initial N-staging of oral squamous cell carcinoma: a cost-effectiveness analysis.
    Burian E; Palla B; Callahan N; Pyka T; Wolff C; von Schacky CE; Schmid A; Froelich MF; Rübenthaler J; Makowski MR; Gassert FG
    Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3870-3877. PubMed ID: 35606526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy.
    Rabalais A; Walvekar RR; Johnson JT; Smith KJ
    Laryngoscope; 2012 Feb; 122(2):311-4. PubMed ID: 22252963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cost-effectiveness analysis of a preventive exercise program for patients with advanced head and neck cancer treated with concomitant chemo-radiotherapy.
    Retèl VP; van der Molen L; Hilgers FJ; Rasch CR; L'Ortye AA; Steuten LM; van Harten WH
    BMC Cancer; 2011 Nov; 11():475. PubMed ID: 22051143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating PET-CT in routine surveillance and follow-up after treatment for cervical cancer: a cost-effectiveness analysis.
    Auguste P; Barton P; Meads C; Davenport C; Małysiak S; Kowalska M; Zapalska A; Guest P; Martin-Hirsch P; Borowiack E; Khan K; Sundar S; Roberts T
    BJOG; 2014 Mar; 121(4):464-76. PubMed ID: 24299112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of the neck after chemoradiotherapy for head and neck cancers in Asia: consensus statement from the Asian Oncology Summit 2009.
    Wee JT; Anderson BO; Corry J; D'Cruz A; Soo KC; Qian CN; Chua DT; Hicks RJ; Goh CH; Khoo JB; Ong SC; Forastiere AA; Chan AT;
    Lancet Oncol; 2009 Nov; 10(11):1086-92. PubMed ID: 19880062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the use of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the workup of Staphylococcus aureus bacteraemia: a cost-utility analysis.
    Ong SWX; Zhabokritsky A; Daneman N; Tong SYC; Wijeysundera HC
    Clin Microbiol Infect; 2023 Nov; 29(11):1417-1423. PubMed ID: 37353076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer.
    Ghaneh P; Hanson R; Titman A; Lancaster G; Plumpton C; Lloyd-Williams H; Yeo ST; Edwards RT; Johnson C; Abu Hilal M; Higginson AP; Armstrong T; Smith A; Scarsbrook A; McKay C; Carter R; Sutcliffe RP; Bramhall S; Kocher HM; Cunningham D; Pereira SP; Davidson B; Chang D; Khan S; Zealley I; Sarker D; Al Sarireh B; Charnley R; Lobo D; Nicolson M; Halloran C; Raraty M; Sutton R; Vinjamuri S; Evans J; Campbell F; Deeks J; Sanghera B; Wong WL; Neoptolemos JP
    Health Technol Assess; 2018 Feb; 22(7):1-114. PubMed ID: 29402376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost effectiveness of cetuximab concurrent with radiotherapy for patients with locally advanced head and neck cancer in Taiwan: a decision-tree analysis.
    Chan AL; Leung HW; Huang SF
    Clin Drug Investig; 2011 Oct; 31(10):717-26. PubMed ID: 21744880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck.
    van der Linden N; van Gils CW; Pescott CP; Buter J; Vergeer MR; Groot CA
    Eur Arch Otorhinolaryngol; 2015 Aug; 272(8):2007-16. PubMed ID: 24943191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.